References
- Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol 2006;90:262-7
- Friedman DS, Wolfs RC, O’Colmain BJ, et al. Prevalence of open-angle glaucoma among adults in the United States. Arch Ophthalmol 2004;122:532-8
- Corp G. In conjunction with cataract surgery, iStent reduces intraocular pressure (IOP) by improving aqueous humor outflow through the physiologic pathway. 2012
- Leske MC, Heijl A, Hyman L, et al. Predictors of long-term progression in the early manifest glaucoma trial. Ophthalmology 2007;114:1965-72
- Vizzeri G, Weinreb RN. Cataract surgery and glaucoma. Curr Opin Ophthalmol 2010;21:20-4
- Nelson P, Aspinall P, Papasouliotis O, et al. Quality of life in glaucoma and its relationship with visual function. J Glaucoma 2003;12:139-50
- Freeman EE, Munoz B, West SK, et al. Glaucoma and quality of life: the Salisbury Eye Evaluation. Ophthalmology 2008;115:233-8
- Prum BE Jr, Rosenberg LF, Gedde SJ, et al. Primary open-angle glaucoma preferred practice pattern® guidelines. Ophthalmology 2016;123:41-111
- Wong MO, Lee JW, Choy BN, Chan JC, Lai JS. Systematic review and meta-analysis on the efficacy of selective laser trabeculoplasty in open-angle glaucoma. Surv Ophthalmol 2015;60:36-50
- Freitas AL, Ushida M, Almeida I, et al. Selective laser trabeculoplasty as an initial treatment option for open-angle glaucoma. Arquivos Brasileiros de Oftalmologia 2016;79:417-21
- Stone JL, Robin AL, Novack GD, et al. An objective evaluation of eyedrop instillation in patients with glaucoma. Arch Ophthalmol 2009;127:732-6
- Rylander NR, Vold SD. Cost analysis of glaucoma medications. Am J Ophthalmol 2008;145:106-13
- Winfield AJ, Jessiman D, Williams A, et al. A study of the causes of non-compliance by patients prescribed eyedrops. Br J Ophthalmol 1990;74:477-80
- Fea AM, Belda JI, Rekas M, et al. Prospective unmasked randomized evaluation of the iStent inject® versus two ocular hypotensive agents in patients with primary open-angle glaucoma. Clin Ophthalmol 2014;8:875-82
- Realini T. Selective laser trabeculoplasty for the management of open-angle glaucoma in St. Lucia. JAMA Ophthalmol 2013;131:321-7
- Vold SD, MIGS Study Group. Prospective, randomized evaluation of micro-invasive glaucoma surgery (MIGS) with two trabecular micro-bypass stents vs prostaglandin in open-angle or pseudoexfoliative glaucoma or ocular hypertension naïve to therapy. Poster #39. American Glaucoma Society Annual Meeting. Coronado, CA; 2015
- Consumer Price Index - All Urban Consumers. 2016. http://data.bls.gov/cgi-bin/surveymost?cu. Accessed July 8, 2016
- Ramsey SD, Willke RJ, Glick H, et al. Cost-effectiveness analysis alongside clinical trials II-An ISPOR Good Research Practices Task Force report. Value Health J Int Soc Pharmacoeconom Outcomes Res 2015;18:161-72
- Varma R, Lee PP, Goldberg I, et al. An assessment of the health and economic burdens of glaucoma. Am J Ophthalmol 2011;152:515-22
- Lee PP, Walt JG, Doyle JJ, et al. A multicenter, retrospective pilot study of resource use and costs associated with severity of disease in glaucoma. Arch Ophthalmol 2006;124:12-9
- Reeder CE, Franklin M, Bramley TJ. Managed care and the impact of glaucoma. Am J Manag Care 2008;14:s5-s10
- Traverso CE, Walt JG, Kelly SP, et al. Direct costs of glaucoma and severity of the disease: a multinational long term study of resource utilisation in Europe. Br J Ophthalmol 2005;89:1245-9
- Nordstrom BL, Friedman DS, Mozaffari E, et al. Persistence and adherence with topical glaucoma therapy. Am J Ophthalmol 2005;140:598-606
- Kass MA, Heuer DK, Higginbotham EJ, et al. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol 2002;120:701-13; discussion 829–30